DENDREON CORP's ticker is DNDNQ and the CUSIP is 24823Q107. A total of 149 filers reported holding DENDREON CORP in Q2 2013. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,250,000 | -70.3% | 75,000 | +511.8% | 0.00% | – |
| Q3 2014 | $17,653,000 | +492.2% | 12,259 | +845.9% | 0.00% | – |
| Q2 2014 | $2,981,000 | +200.2% | 1,296 | +236.6% | 0.00% | – |
| Q1 2014 | $993,000 | -100.0% | 385 | -100.0% | 0.00% | -100.0% |
| Q4 2013 | $445,340,293,000 | +391755.9% | 7,000,098 | +17947.1% | 0.16% | – |
| Q3 2013 | $113,649,000 | -77.4% | 38,788 | -68.2% | 0.00% | – |
| Q2 2013 | $502,619,000 | – | 121,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MILLER VALUE PARTNERS, LLC | 2,405,400 | $9,911,000 | 0.68% |
| TRAXIS PARTNERS LP | 200,000 | $824,000 | 0.64% |
| Cooperatieve Rabobank U.A. | 371,297 | $1,530,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,500,000 | $10,300,000 | 0.48% |
| SECTOR GAMMA AS | 345,000 | $1,421,000 | 0.41% |
| Orbimed Advisors | 4,102,300 | $16,901,000 | 0.36% |
| MANGROVE PARTNERS IM, LLC | 200,000 | $824,000 | 0.35% |
| BB BIOTECH AG | 1,014,800 | $4,181,000 | 0.30% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 5,913,400 | $24,363,000 | 0.26% |
| Tekla Capital Management LLC | 376,728 | $1,552,000 | 0.21% |